Menu
Pulmonology / Respiratory

Sarcoidosis (Stage IV - Fibrotic)

ICD-10 Code
D86.0_1

Clinical Criteria for Sarcoidosis (Stage IV - Fibrotic).

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient presents for follow-up of Stage IV pulmonary sarcoidosis. Reports progressive exertional dyspnea (mMRC grade [X]), chronic non-productive cough, and intermittent pleuritic chest pain. Denies hemoptysis, orthopnea, or paroxysmal nocturnal dyspnea. Current symptoms stable/worsening compared to prior visit. Review of systems significant for fatigue, weight loss, and exercise intolerance.

Clinical Examination Findings

General: Patient appears chronically ill, resting tachypnea noted. Vitals: SpO2 [X]% on room air/supplemental O2 at [X]L/min. Chest: Auscultation reveals bilateral fine end-inspiratory crackles, predominantly in upper lobes. Diminished breath sounds at bases. Cardiac: Regular rate and rhythm, loud P2 component suggesting pulmonary hypertension. Extremities: No clubbing or peripheral edema. Skin: No sarcoid plaques or nodules observed.

Treatment Protocol

Plan: 1. Optimize immunosuppressive therapy: Continue [Prednisone/Methotrexate/Azathioprine] at current dosage. 2. Pulmonary rehabilitation referral to improve exercise tolerance. 3. Long-term oxygen therapy (LTOT) initiated at [X]L/min for exertional hypoxemia. 4. Monitor pulmonary function tests (PFTs) and DLCO every [X] months. 5. Annual screening for pulmonary hypertension via echocardiography.

Detailed clinical guide coming soon.